Table 1.
Baseline clinical characteristics according to antidiabetes group
| All | D group | MF group | MF/Rosi group | |
|---|---|---|---|---|
| n | 97 | 35 | 30 | 32 |
| Age (years) | 76 ± 6 | 77 ± 6 | 75 ± 6 | 76 ± 6 |
| Sex (male/female) | 53/44 | 18/17 | 17/13 | 18/14 |
| Diabetes (years) | 5.7 ± 3.3 | 5.2 ± 3.3 | 5.6 ± 2.9 | 6.1 ± 3.7 |
| BMI (kg/m2) | 27.7 ± 3.5 | 28.3 ± 3.9 | 27.3 ± 3.4 | 27.4 ± 3.0 |
| Waist-to-hip ratio | 0.89 ± 0.8 | 0.90 ± 0.8 | 0.89 ± 0.8 | 0.91 ± 0.8 |
| FPG (mmol/l) | 8.44 ± 1.11 | 8.44 ± 1.22 | 8.28 ± 0.94 | 8.5 ± 0.89 |
| FPI (pmol/l) | 148 ± 74 | 150 ± 75 | 149 ± 73 | 147 ± 13 |
| A1C (%) | 7.5 ± 0.5 | 7.5 ± 0.4 | 7.4 ± 0.6 | 7.5 ± 0.4 |
| Cholesterol (mmol/l) | 5.68 ± 0.83 | 5.71 ± 0.75 | 5.68 ± 0.85 | 5.63 ± 0.93 |
| LDL (mmol/l) | 3.46 ± 0.85 | 3.49 ± 0.80 | 3.51 ± 0.85 | 3.39 ± 0.93 |
| HDL (mmol/l) | 1.01 ± 0.28 | 1.03 ± 0.31 | 1.01 ± 0.28 | 0.98 ± 0.26 |
| Triglycerides (mmol/l) | 2.55 ± 0.58 | 2.56 ± 0.7 | 2.48 ± 0.56 | 2.60 ± 0.45 |
| Systolic blood pressure (mmHg) | 150 ± 21 | 150 ± 19 | 147 ± 18 | 153 ± 24 |
| Diastolic blood pressure (mmHg) | 85 ± 7 | 85 ± 7 | 85 ± 7 | 84 ± 7 |
| Ejection fraction (%) | 52.7 ± 2.9 | 53.9 ± 2.5 | 52.4 ± 2.2 | 51.7 ± 3.2 |
| Physical activity* | 2.8 ± 1.0 | 2.8 ± 1.0 | 2.7 ± 1.1 | 2.8 ± 1.0 |
| MMSE | 24.0 ± 2.5 | 22.9 ± 2.1 | 24.1 ± 2.3 | 24.0 ± 3.0 |
| TMT-A (s) | 67.6 ± 42.6 | 72.2 ± 46.5 | 61.5 ± 30.6 | 67.8 ± 48.1 |
| TMT-B (s) | 161.1 ± 63.7 | 158.7 ± 60.0 | 172.7 ± 61.8 | 162.5 ± 76.8 |
| DIFFBA (s) | 101.2 ± 58.1 | 111.6 ± 60.1 | 95.0 ± 44.9 | 98.2 ± 68.1 |
| RAVLT | 24.5 ± 2.3 | 24.8 ± 2.5 | 24.7 ± 2.2 | 24.0 ± 2.1 |
Data are means ± SD.
*According to EPIC questionnaire (see research design and methods).